rs571095192
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2
The NM_012186.3(FOXE3):c.929G>A(p.Gly310Asp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000666 in 1,355,330 control chromosomes in the GnomAD database, including 14 homozygotes. In-silico tool predicts a benign outcome for this variant. 12/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Synonymous variant affecting the same amino acid position (i.e. G310G) has been classified as Likely benign.
Frequency
Consequence
NM_012186.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -20 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
FOXE3 | NM_012186.3 | c.929G>A | p.Gly310Asp | missense_variant | 1/1 | ENST00000335071.4 | |
LINC01389 | NR_126355.1 | n.29-7343C>T | intron_variant, non_coding_transcript_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
FOXE3 | ENST00000335071.4 | c.929G>A | p.Gly310Asp | missense_variant | 1/1 | NM_012186.3 | P1 |
Frequencies
GnomAD3 genomes AF: 0.00153 AC: 232AN: 151904Hom.: 2 Cov.: 33
GnomAD3 exomes AF: 0.00360 AC: 68AN: 18914Hom.: 2 AF XY: 0.00246 AC XY: 29AN XY: 11812
GnomAD4 exome AF: 0.000557 AC: 670AN: 1203312Hom.: 12 Cov.: 34 AF XY: 0.000542 AC XY: 318AN XY: 586506
GnomAD4 genome AF: 0.00153 AC: 232AN: 152018Hom.: 2 Cov.: 33 AF XY: 0.00164 AC XY: 122AN XY: 74326
ClinVar
Submissions by phenotype
not specified Benign:3
Benign, no assertion criteria provided | clinical testing | Genome Diagnostics Laboratory, University Medical Center Utrecht | - | - - |
Benign, criteria provided, single submitter | clinical testing | Eurofins Ntd Llc (ga) | Aug 04, 2016 | - - |
Likely benign, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | Jul 29, 2023 | - - |
not provided Benign:2
Likely benign, criteria provided, single submitter | clinical testing | ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories | Mar 29, 2023 | - - |
Likely benign, no assertion criteria provided | clinical testing | Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center | - | - - |
Congenital primary aphakia;C1862839:Anterior segment dysgenesis Benign:1
Benign, criteria provided, single submitter | clinical testing | Invitae | Jan 29, 2024 | - - |
Cardiovascular phenotype Benign:1
Benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 05, 2019 | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at